0001567892-21-000037.txt : 20211102 0001567892-21-000037.hdr.sgml : 20211102 20211102064008 ACCESSION NUMBER: 0001567892-21-000037 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20211102 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20211102 DATE AS OF CHANGE: 20211102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mallinckrodt plc CENTRAL INDEX KEY: 0001567892 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981088325 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35803 FILM NUMBER: 211369192 BUSINESS ADDRESS: STREET 1: COLLEGE BUSINESS & TECHNOLOGY PARK STREET 2: CRUISERATH, BLANCHARDSTOWN CITY: DUBLIN 15 STATE: L2 ZIP: D15 BUSINESS PHONE: 353 1 6960000 MAIL ADDRESS: STREET 1: COLLEGE BUSINESS & TECHNOLOGY PARK STREET 2: CRUISERATH, BLANCHARDSTOWN CITY: DUBLIN 15 STATE: L2 ZIP: D15 8-K 1 mnk-20211102.htm 8-K mnk-20211102
0001567892false00015678922021-11-022021-11-02


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): November 2, 2021
 
Mallinckrodt plc
(Exact name of registrant as specified in its charter)
Ireland001-3580398-1088325
(State or other jurisdiction
of incorporation)		(Commission
File Number)		(IRS Employer
 Identification No.)

College Business & Technology Park, Cruiserath,
Blanchardstown, Dublin 15, Ireland
(Address of principal executive offices) (Zip Code)
 
Registrant's telephone number, including area code:  +353 1 696 0000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: None
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐




Item 2.02    Results of Operations and Financial Condition.
On November 2, 2021, Mallinckrodt plc (the "Company" or "Mallinckrodt") provided its financial results for the three and nine months ended September 24, 2021 in the attached Exhibit 99.1.
The information in this Current Report on Form 8-K, including Exhibit 99.1, should be read in conjunction with the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 24, 2021.
The information contained in this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, except as otherwise expressly set forth by specific reference in such a filing.
NON-GAAP FINANCIAL MEASURES
Exhibit 99.1 contains financial measures, including adjusted EBITDA and net sales growth on a constant-currency basis, which are considered "non-GAAP" financial measures under applicable U.S. Securities and Exchange Commission rules and regulations.
Adjusted EBITDA represents amounts prepared in accordance with accounting principles generally accepted in the U.S. (GAAP) and adjusts for certain items that management believes are not reflective of the operational performance of the business. Consolidated adjusted EBITDA represents net loss, adjusted for interest expense, net, taxes, depreciation and amortization and certain items that management believes are not reflective of the operational performance of the business and additional adjustments. These adjustments include, but are not limited to, restructuring charges, net; non-restructuring impairment charges; discontinued operations; changes in fair value of contingent consideration obligations; significant legal and environmental charges; divestitures; separation costs; unrealized gain on equity investment; reorganization items, net; share-based compensation and other items identified by the Company.
Segment net sales growth on a constant-currency basis measures the change in segment net sales between current- and prior-year periods using a constant currency, the exchange rate in effect during the applicable prior-year period.
The Company has provided these adjusted financial measures because they are used by management, along with financial measures in accordance with GAAP, to evaluate the company's operating performance. In addition, the Company believes that they will be used by certain investors to measure Mallinckrodt's operating results. Management believes that presenting these adjusted measures provides useful information about the Company's performance across reporting periods on a consistent basis by excluding items that the Company does not believe are indicative of its core operating performance. Reconciliations of these financial measures to the most directly comparable GAAP financial measures are included in Exhibit 99.1.
These adjusted measures should be considered supplemental to and not a substitute for financial information prepared in accordance with GAAP.

Item 9.01    Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.Exhibit
99.1
104Cover Page Interactive Data File (embedded within the inline XBRL document).



SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MALLINCKRODT PLC
(registrant)
Date:November 2, 2021By: /s/ Bryan M. Reasons
Bryan M. Reasons
Executive Vice President and Chief Financial Officer
(principal financial officer)



 EX-99.1 2 mnkexhibit991q32021.htm EX-99.1 Document

Exhibit 99.1

MALLINCKRODT PLC
(DEBTOR-IN-POSSESSION)
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited, in millions, except per share data)
Three Months Ended
September 24,
2021		Percent of
Net sales		September 25,
2020		Percent of
Net sales
Net sales
$507.2 100.0 %$698.3 100.0 %
Cost of sales319.2 62.9 403.0 57.7 
Gross profit188.0 37.1 295.3 42.3 
Selling, general and administrative expenses127.3 25.1 220.8 31.6 
Research and development expenses47.3 9.3 65.5 9.4 
Restructuring charges, net11.0 2.2 3.2 0.5 
Gains on divestiture— — (9.7)(1.4)
Opioid-related litigation settlement loss (gain)125.0 24.6 (25.8)(3.7)
Medicaid lawsuit— — (0.2)— 
Operating (loss) income(122.6)(24.2)41.5 5.9 
Interest expense(48.7)(9.6)(62.2)(8.9)
Interest income— — 0.9 0.1 
Other expense, net(3.5)(0.7)— — 
Reorganization items, net(126.2)(24.9)— — 
Loss from continuing operations before income taxes(301.0)(59.3)(19.8)(2.8)
Income tax benefit(32.0)(6.3)(211.6)(30.3)
(Loss) income from continuing operations(269.0)(53.0)191.8 27.5 
Income (loss) from discontinued operations, net of income taxes5.3 1.0 (0.2)— 
Net (loss) income$(263.7)(52.0)%$191.6 27.4 %
Basic (loss) income per share:
(Loss) income from continuing operations$(3.18)$2.27 
Income (loss) from discontinued operations0.06 — 
Net (loss) income$(3.11)$2.26 
Diluted (loss) income per share:
(Loss) income from continuing operations$(3.18)$2.27 
Income (loss) from discontinued operations0.06 — 
Net (loss) income$(3.11)$2.26 
Weighted-average number of shares outstanding
Basic84.784.6
Diluted84.784.6




1

MALLINCKRODT PLC
(DEBTOR-IN-POSSESSION)
CONSOLIDATED ADJUSTED EBITDA
(unaudited, in millions)
Three Months Ended
September 24, 2021September 25, 2020
Gross ProfitSG&AR&DAdjusted EBITDAGross ProfitSG&AR&DAdjusted EBITDA
Net loss$188.0 $127.3 $47.3 $(263.7)$295.3 $220.8 $65.5 $191.6 
Adjustments:
Interest expense, net— — — 48.7 — — — 61.3 
Income taxes— — — (32.0)— — — (211.6)
Depreciation (1)
17.3 (4.3)(1.6)23.2 18.3 (5.5)(1.7)25.5 
Amortization144.5 (0.8)— 145.3 209.7 (0.9)— 210.6 
Restructuring charges, net— — — 11.0 — — — 3.2 
(Income) loss from discontinued operations— — — (5.3)— — — 0.2 
Change in contingent consideration fair value— 2.1 — (2.1)— (8.1)— 8.1 
Significant legal and environmental charges— — — 125.0 0.7 (13.4)— (11.9)
Gains on divestiture— — — — — — — (9.7)
Separation costs— (0.1)— 0.1 — (33.0)— 33.0 
Unrealized loss on equity investment— — — 6.9 — — — 0.8 
Reorganization items, net— — — 126.2 — — — — 
Share-based compensation 0.1 (1.9)(0.4)2.4 0.2 (3.4)(0.7)4.3 
As adjusted:$349.9 $122.3 $45.3 $185.7 $524.2 $156.5 $63.1 $305.4 
(1)Includes $0.7 millions of accelerated depreciation in selling general and administrative ("SG&A") related to restructuring charges incurred during the three months ended September 24, 2021.



2

MALLINCKRODT PLC
(DEBTOR-IN-POSSESSION)
SEGMENT OPERATING INCOME
(unaudited, in millions)
Three Months Ended
September 24,
2021		September 25,
2020
Specialty Brands$189.9 $291.8 
Specialty Generics15.2 43.1 
Segment operating income205.1 334.9 
Unallocated amounts:
Corporate and unallocated expenses (1)
(20.8)(42.1)
Depreciation and amortization(168.4)(236.1)
Share-based compensation(2.4)(4.3)
Restructuring charges, net(11.0)(3.2)
Separation costs(0.1)(33.0)
Opioid-related litigation settlement (loss) gain(125.0)25.8 
Medicaid lawsuit— (0.5)
Operating (loss) income$(122.6)$41.5 
(1)Includes administration expenses and certain compensation, legal, environmental and other costs not charged to the Company's reportable segments.
3

MALLINCKRODT PLC
(DEBTOR-IN-POSSESSION)
SEGMENT NET SALES AND CONSTANT-CURRENCY GROWTH
(unaudited, in millions)
Three Months Ended
September 24,
2021		September 25,
2020		Percent
change		Currency impactConstant-currency growth
Specialty Brands$359.7 $539.6 (33.3)%0.1 %(33.4)%
Specialty Generics147.5 159.4 (7.5)0.1 (7.6)
Segment net sales507.2 699.0 (27.4)0.1 (27.5)
Medicaid lawsuit— (0.7)***
Net sales$507.2 $698.3 (27.4)%0.1 %(27.5)%
*Not meaningful


MALLINCKRODT PLC
(DEBTOR-IN-POSSESSION)
SELECT PRODUCT LINE NET SALES AND CONSTANT-CURRENCY GROWTH
(unaudited, in millions)
Three Months Ended
September 24,
2021		September 25,
2020		Percent
change		Currency impactConstant-currency growth
Specialty Brands
Acthar Gel $143.4 $195.3 (26.6)%— %(26.6)%
INOmax98.4 141.9 (30.7)— (30.7)
Ofirmev4.7 88.7 (94.7)— (94.7)
Therakos62.5 62.6 (0.2)0.7 (0.9)
Amitiza49.6 47.7 4.0 — 4.0 
Other1.1 3.4 (67.6)— (67.6)
Specialty Brands Total359.7 539.6 (33.3)0.1 (33.4)
Specialty Generics
Hydrocodone (API) and hydrocodone-containing tablets16.9 20.0 (15.5)— (15.5)
Oxycodone (API) and oxycodone-containing tablets15.2 16.1 (5.6)— (5.6)
Acetaminophen (API)49.6 54.9 (9.7)— (9.7)
Other controlled substances60.8 62.4 (2.6)0.3 (2.9)
Other5.0 6.0 (16.7)— (16.7)
Specialty Generics Total147.5 159.4 (7.5)0.1 (7.6)
Segment net sales507.2 699.0 (27.4)0.1 (27.5)
Medicaid lawsuit— (0.7)***
Net sales$507.2 $698.3 (27.4)%0.1 %(27.5)%
*Not meaningful



4

MALLINCKRODT PLC
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited, in millions, except per share data)
Nine Months Ended
September 24,
2021		Percent of
Net sales		September 25,
2020		Percent of
Net sales
Net sales (includes refined estimate of the retrospective one-time charge of $535.1 million related to the Medicaid lawsuit for the nine months ended September 25, 2020)
$1,611.6 100.0 %$1,530.6 100.0 %
Cost of sales958.4 59.5 1,171.7 76.6 
Gross profit653.2 40.5 358.9 23.4 
Selling, general and administrative expenses408.3 25.3 683.2 44.6 
Research and development expenses166.3 10.3 225.8 14.8 
Restructuring charges, net17.5 1.1 15.8 1.0 
Non-restructuring impairment charges64.5 4.0 63.5 4.1 
Losses (gains) on divestiture0.8 — (10.1)(0.7)
Opioid-related litigation settlement loss (gain)125.0 7.8 (34.1)(2.2)
Medicaid lawsuit— — 105.1 6.9 
Operating loss(129.2)(8.0)(690.3)(45.1)
Interest expense(160.7)(10.0)(200.9)(13.1)
Interest income1.9 0.1 5.4 0.4 
Other income, net15.9 1.0 1.1 0.1 
Reorganization items, net(329.2)(20.4)— — 
Loss from continuing operations before income taxes
(601.3)(37.3)(884.7)(57.8)
Income tax benefit(81.9)(5.1)(69.2)(4.5)
Loss from continuing operations(519.4)(32.2)(815.5)(53.3)
Income from discontinued operations, net of income taxes
6.0 0.4 23.8 1.6 
Net loss$(513.4)(31.9)%$(791.7)(51.7)%
Basic loss per share:
Loss from continuing operations$(6.13)$(9.66)
Income from discontinued operations0.07 0.28 
Net loss$(6.06)$(9.38)
Diluted loss per share:
Loss from continuing operations$(6.13)$(9.66)
Income from discontinued operations0.07 0.28 
Net loss$(6.06)$(9.38)
Weighted-average number of shares outstanding:
Basic84.784.4
Diluted84.784.4
5

MALLINCKRODT PLC
(DEBTOR-IN-POSSESSION)
CONSOLIDATED ADJUSTED EBITDA
(unaudited, in millions)
Nine Months Ended
September 24, 2021September 25, 2020
Gross ProfitSG&AR&DAdjusted EBITDAGross ProfitSG&AR&DAdjusted EBITDA
Net loss$653.2 $408.3 $166.3 $(513.4)$358.9 $683.2 $225.8 $(791.7)
Adjustments:
Interest expense, net— — — 158.8 — — — 195.5 
Income tax benefit— — — (81.9)— — — (69.2)
Depreciation (1)
52.2 (13.4)(4.7)70.3 54.2 (16.3)(5.2)75.7 
Amortization433.3 (2.5)— 435.8 597.2 (2.6)— 599.8 
Restructuring charges, net— — — 17.5 — — — 15.8 
Non-restructuring impairment charges— — — 64.5 — — — 63.5 
Income from discontinued operations— — — (6.0)— — — (23.8)
Change in contingent consideration fair value— 7.6 — (7.6)— (2.4)— 2.4 
Significant legal and environmental charges— — — 125.0 535.1 (53.1)— 659.2 
Losses (gains) on divestiture— — — 0.8 — — — (10.1)
Separation costs— (1.0)— 1.0 — (75.0)— 75.0 
Unrealized gain on equity investment— — — (4.8)— — — (2.2)
R&D upfront payment— — — — — — (5.0)5.0 
Reorganization items, net— — — 329.2 — — — — 
Share-based compensation 0.4 (6.6)(1.4)8.4 0.8 (14.0)(2.8)17.6 
As adjusted:$1,139.1 $392.4 $160.2 $597.6 $1,546.2 $519.8 $212.8 $812.5 
(1)Includes $2.0 million of accelerated depreciation in SG&A related to restructuring charges incurred during the nine months ended September 24, 2021.

6

MALLINCKRODT PLC
(DEBTOR-IN-POSSESSION)
SEGMENT OPERATING INCOME
(unaudited, in millions)
Nine Months Ended
September 24,
2021		September 25,
2020
Specialty Brands$588.6 $765.0 
Specialty Generics73.8 155.5 
Segment operating income662.4 920.5 
Unallocated amounts:
Corporate and unallocated expenses (1)
(69.1)(152.3)
Depreciation and amortization(506.1)(675.5)
Share-based compensation(8.4)(17.6)
Restructuring charges, net(17.5)(15.8)
Non-restructuring impairment charges(64.5)(63.5)
Separation costs(1.0)(75.0)
R&D upfront payment— (5.0)
Opioid-related litigation settlement (loss) gain(125.0)34.1 
Medicaid lawsuit— (640.2)
Operating loss$(129.2)$(690.3)
(1)Includes administration expenses and certain compensation, legal, environmental and other costs not charged to the Company's reportable segments.


7


MALLINCKRODT PLC
(DEBTOR-IN-POSSESSION)
SEGMENT NET SALES AND CONSTANT-CURRENCY GROWTH
(unaudited, in millions)
Nine Months Ended
September 24,
2021		September 25,
2020		Percent
change		Currency impactConstant-currency growth
Specialty Brands$1,149.6 $1,553.0 (26.0)%0.3 %(26.3)%
Specialty Generics462.0 512.7 (9.9)0.1 (10.0)
Segment net sales1,611.6 2,065.7 (22.0)0.2 (22.2)
Medicaid lawsuit— (535.1)***
Net sales$1,611.6 $1,530.6 5.3 %0.2 %5.1 %
*Not meaningful

MALLINCKRODT PLC
(DEBTOR-IN-POSSESSION)
SELECT PRODUCT LINE NET SALES
(unaudited, in millions)
Nine Months Ended
September 24,
2021		September 25,
2020		Percent
change		Currency impactConstant-currency growth
Specialty Brands
Acthar$423.9 $576.6 (26.5)%— %(26.5)%
Inomax338.3 438.5 (22.9)0.1 (23.0)
Ofirmev24.0 216.0 (88.9)— (88.9)
Therakos197.8 174.1 13.6 2.1 11.5 
Amitiza155.8 138.2 12.7 — 12.7 
Other9.8 9.6 2.1 — 2.1 
Specialty Brands Total1,149.6 1,553.0 (26.0)0.3 (26.3)
Specialty Generics
Hydrocodone (API) and hydrocodone-containing tablets60.7 71.9 (15.6)— (15.6)
Oxycodone (API) and oxycodone-containing tablets49.5 48.0 3.1 — 3.1 
Acetaminophen (API)146.8 154.5 (5.0)— (5.0)
Other controlled substances187.9 223.8 (16.0)0.3 (16.3)
Other17.1 14.5 17.9 — 17.9 
Specialty Generics Total462.0 512.7 (9.9)0.1 (10.0)
Segment net sales1,611.6 2,065.7 (22.0)0.2 (22.2)
Medicaid lawsuit— (535.1)***
Net sales$1,611.6 $1,530.6 5.3 %0.2 %5.1 %
*Not meaningful



8

MALLINCKRODT PLC
(DEBTOR-IN-POSSESSION)
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited, in millions)
September 24,
2021		December 25,
2020
Assets
Current Assets:
Cash and cash equivalents$1,322.6 $1,070.6 
Accounts receivable, net431.7 538.8 
Inventories367.6 344.9 
Prepaid expenses and other current assets203.7 350.0 
Total current assets2,325.6 2,304.3 
Property, plant and equipment, net767.7 833.1 
Intangible assets, net5,684.1 6,184.5 
Other assets380.6 393.5 
Total Assets$9,158.0 $9,715.4 
Liabilities and Shareholders' Equity
Current Liabilities:
Current maturities of long-term debt$1,388.1 $3,587.9 
Accounts payable122.2 93.3 
Accrued payroll and payroll-related costs62.7 79.4 
Accrued interest25.7 26.9 
Accrued and other current liabilities387.1 331.2 
Total current liabilities1,985.8 4,118.7 
Pension and postretirement benefits32.6 34.6 
Environmental liabilities60.3 59.8 
Deferred income taxes61.5 80.6 
Other income tax liabilities82.9 100.1 
Other liabilities86.0 109.8 
Liabilities subject to compromise6,335.5 4,192.6 
Total Liabilities8,644.6 8,696.2 
Shareholders' Equity:
Preferred shares— — 
Ordinary shares
18.9 18.8 
Ordinary shares held in treasury at cost(1,616.1)(1,616.1)
Additional paid-in capital5,596.0 5,587.6 
Retained deficit(3,474.9)(2,961.5)
Accumulated other comprehensive loss(10.5)(9.6)
Total Shareholders' Equity513.4 1,019.2 
Total Liabilities and Shareholders' Equity$9,158.0 $9,715.4 


9

MALLINCKRODT PLC
(DEBTOR-IN-POSSESSION)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited, in millions)
Nine Months Ended
September 24,
2021		September 25,
2020
Cash Flows From Operating Activities:
Net loss$(513.4)$(791.7)
Adjustments to reconcile net cash from operating activities:
Depreciation and amortization506.1 675.5 
Share-based compensation8.4 17.6 
Deferred income taxes(19.1)304.0 
Non-cash impairment charges64.5 63.5 
Losses (gains) on divestiture0.8 (10.1)
Reorganization items, net22.5 — 
Other non-cash items(6.0)(21.6)
Changes in assets and liabilities:
Accounts receivable, net105.7 61.1 
Inventories(30.9)(43.9)
Accounts payable14.7 (52.4)
Income taxes92.5 (431.2)
Opioid-related litigation settlement liability125.0 — 
Medicaid lawsuit(4.8)640.2 
Other40.4 (116.3)
Net cash from operating activities406.4 294.7 
Cash Flows From Investing Activities:
Capital expenditures(39.2)(42.4)
Proceeds from divestitures, net of cash15.7 (0.7)
Other1.4 6.7 
Net cash from investing activities(22.1)(36.4)
Cash Flows From Financing Activities:
Repayment of external debt(128.2)(134.6)
Debt financing costs— (9.3)
Repurchase of shares— (0.4)
Other— (36.3)
Net cash from financing activities(128.2)(180.6)
Effect of currency rate changes on cash(0.9)0.2 
Net change in cash, cash equivalents and restricted cash255.2 77.9 
Cash, cash equivalents and restricted cash at beginning of period1,127.0 822.6 
Cash, cash equivalents and restricted cash at end of period$1,382.2 $900.5 
Cash and cash equivalents at end of period$1,322.6 $844.2 
Restricted cash included in prepaid expenses and other assets at end of period23.3 20.2 
Restricted cash included in other long-term assets at end of period36.3 36.1 
Cash, cash equivalents and restricted cash at end of period$1,382.2 $900.5 
10
 EX-101.SCH 3 mnk-20211102.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Document and Entity Information Document link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 mnk-20211102_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Country Region Country Region Document Type Document Type Entity Address, Postal Zip Code Entity Address, Postal Zip Code Local Phone Number Local Phone Number Amendment Flag Amendment Flag City Area Code City Area Code Written Communications Written Communications Entity Address, Address Line Three Entity Address, Address Line Three Document and Entity Information [Abstract] Document and Entity Information [Abstract] Document and Entity Information [Abstract] Soliciting Material Soliciting Material Document Period End Date Document Period End Date Entity Address, City or Town Entity Address, City or Town Entity Tax Identification Number Entity Tax Identification Number Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Address, Address Line One Entity Address, Address Line One Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Country Entity Address, Country Entity Emerging Growth Company Entity Emerging Growth Company Entity Registrant Name Entity Registrant Name Entity File Number Entity File Number Entity Central Index Key Entity Central Index Key EX-101.PRE 5 mnk-20211102_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 mnk-20211102_htm.xml IDEA: XBRL DOCUMENT 0001567892 2021-11-02 2021-11-02 0001567892 false 8-K 2021-11-02 Mallinckrodt plc L2 001-35803 98-1088325 College Business & Technology Park Cruiserath Blanchardstown Dublin 15 IE 353 1 696 0000 false false false false false XML 7 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Document and Entity Information Document
Nov. 02, 2021
Document and Entity Information [Abstract]  
Entity Central Index Key 0001567892
Written Communications false
Entity Incorporation, State or Country Code L2
Document Type 8-K
Document Period End Date Nov. 02, 2021
Entity Registrant Name Mallinckrodt plc
Entity File Number 001-35803
Entity Tax Identification Number 98-1088325
Entity Address, Address Line One College Business & Technology Park
Entity Address, City or Town Dublin
Entity Address, Postal Zip Code 15
Entity Address, Country IE
City Area Code 1
Local Phone Number 696 0000
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Amendment Flag false
Entity Address, Address Line Two Cruiserath
Entity Address, Address Line Three Blanchardstown
Country Region 353
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 1 97 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Document and Entity Information Document Sheet http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument Document and Entity Information Document Cover 1 false false All Reports Book All Reports mnk-20211102.htm mnk-20211102.xsd mnk-20211102_lab.xml mnk-20211102_pre.xml mnkexhibit991q32021.htm http://xbrl.sec.gov/dei/2020-01-31 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "mnk-20211102.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "mnk-20211102.htm" ] }, "labelLink": { "local": [ "mnk-20211102_lab.xml" ] }, "presentationLink": { "local": [ "mnk-20211102_pre.xml" ] }, "schema": { "local": [ "mnk-20211102.xsd" ], "remote": [ "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 97, "memberCustom": 0, "memberStandard": 0, "nsprefix": "mnk", "nsuri": "http://www.mallinckrodt.com/20211102", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mnk-20211102.htm", "contextRef": "i7fedd8ab463e49769027ee954002e093_D20211102-20211102", "decimals": null, "first": true, "lang": "en-US", "name": "dei:WrittenCommunications", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Document and Entity Information Document", "role": "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument", "shortName": "Document and Entity Information Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mnk-20211102.htm", "contextRef": "i7fedd8ab463e49769027ee954002e093_D20211102-20211102", "decimals": null, "first": true, "lang": "en-US", "name": "dei:WrittenCommunications", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region", "terseLabel": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three", "terseLabel": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.mallinckrodt.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "mnk_DocumentandEntityInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Document and Entity Information [Abstract]", "label": "Document and Entity Information [Abstract]", "terseLabel": "Document and Entity Information [Abstract]" } } }, "localname": "DocumentandEntityInformationAbstract", "nsuri": "http://www.mallinckrodt.com/20211102", "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r3": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r4": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 14 0001567892-21-000037-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001567892-21-000037-xbrl.zip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end